mdlinx mdlinx
Latest (24) Full Text Articles (287) Focus on Osteoporosis Article Summary

The pattern-recognition receptor NOD1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts
Arthritis & Rheumatism, 05/04/2012

Yokota K et al. – NOD–1 is strongly expressed in different cell types in the synovial tissue of patients with rheumatoid arthritis (RA). These results indicate that NOD–1, either alone or interacting with other inflammatory mediators, can play an important role in the chronic and destructive inflammation of the joints in RA.

Methods
  • Expression of NOD–1 was analyzed by immunohistochemistry in synovial tissue from RA patients, psoriatic arthritis patients, gout patients, and osteoarthritis (OA) patients.
  • RASFs and human monocyte–derived macrophages (HMDMs) were stimulated with L–alanyl–γ–D–glutamyl–meso–diaminopimelic acid, palmitoyl–3–cysteine–serine–lysine–4, poly(I–C), lipopolysaccharide, heat–inactivated bacteria, tumor necrosis factor α (TNF α), or interleukin–1 β (IL–1 β).
  • Expression levels of IL–6, CCL5, matrix metalloproteinases (MMPs), NODs, and TLRs were measured by real–time reverse transcription–polymerase chain reaction and/or enzyme–linked immunosorbent assay.
  • NOD–1 and NOD–2 were silenced with target–specific small interfering RNA.
  • Phosphorylation of IL–1 receptor–associated kinase 1 (IRAK–1) was measured by Western blotting.

Results
  • Expression of NOD–1 protein was significantly increased in RA synovium compared to OA synovium.
  • The basal expression of NOD–1 was similar in RASFs, OASFs, healthy control peripheral blood mononuclear cells, and healthy control HMDMs.
  • Stimulation of RASFs with TLR–3 up–regulated the expression of NOD–1.
  • Expression of IL–6, CCL5, MMPs, TLR–2, and NOD–2 was significantly up–regulated in RASFs by stimulation with the NOD–1 ligand.
  • A synergistic effect on IL–6 production was observed in cells stimulated with NOD–1 and TLR–2 ligands or NOD–1 and TLR–4 ligands.
  • Silencing of NOD–1, but not NOD–2, decreased the levels of IL–6 in RASFs after stimulation with TLR–2 and IL–1β, and blocked the phosphorylation of IRAK–1.

► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Rheumatology Articles

Last month's top read Top Articles of 2012

1 Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Current Medical Research and Opinion, April 3, 2013    Clinical Article

2 Antibiotics for Treatment of Reactive Arthritis: A Systematic Review and Metaanalysis The Journal of Rheumatology, April 18, 2013    Continuing Medical Education    Evidence Based Medicine    Review Article

3 EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Annals of Rheumatic Diseases, April 10, 2013    Clinical Article

4 Targeted therapies for systemic sclerosis Nature Reviews Rheumatology , April 10, 2013    Clinical Article

5 Complementary and alternative exercise for fibromyalgia: a meta-analysis Full Text Journal of Pain Research, April 2, 2013    Free full text    Clinical Article

6 Late-onset systemic lupus erythematosus: clinical features, course, and prognosis Clinical Rheumatology, March 26, 2013    Clinical Article

7 Statin Use in Giant Cell Arteritis: A Retrospective Study The Journal of Rheumatology, April 3, 2013    Clinical Article

8 Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs Journal of Multidisciplinary Healthcare, April 4, 2013    Review Article    Clinical Guideline

9 Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program The Journal of Rheumatology, April 16, 2013    Clinical Article

10 New therapeutics in systemic lupus erythematosus Current Opinion in Rheumatology, April 1, 2013    Clinical Article

11 New treatments for osteoarthritis Current Opinion in Rheumatology, March 29, 2013    Clinical Article

12 The association of gout with sleep disorders: a cross-sectional study in primary care Full Text BMC Musculoskeletal Disorders, April 5, 2013    Free full text    Clinical Article

13 Intra-articular corticosteroid injection in osteoarthritis of the knee and hip: Factors predicting pain relief--A systematic review Seminars in Arthritis and Rheumatism, February 4, 2013    Evidence Based Medicine    Clinical Article

14 Novel aspects of Sjogren's syndrome in 2012 Full Text BMC Medicine, April 16, 2013    Free full text    Clinical Article

15 Creatine supplementation in fibromyalgia: A double-blind, randomized, placebo-controlled trial Arthritis Care & Research , April 3, 2013    Clinical Article

16 Current diagnostic tools for Sjogrens syndrome International Journal of Clinical Rheumatology, April 3, 2013    Clinical Article

17 A meta-analysis of healing and prevention of digital ulcers (DU) in systemic sclerosis (SSc) Arthritis Care & Research , April 2, 2013    Evidence Based Medicine    Clinical Article

18 The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus The Journal of Rheumatology, April 18, 2013    Clinical Article

19 The impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis (RA) vs. non-RA subjects: Results from a population-based study Arthritis Care & Research , April 17, 2013    Clinical Article

20 Safety of Rituximab in Combination with Other Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: An Open-label Study The Journal of Rheumatology, April 2, 2013    Clinical Article

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Other Topics in Rheumatology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close